ARWR vs JNPR · rev $829.4M vs P/E 38, $13.36B cap
Arrowhead Pharmaceuticals Inc (ARWR) versus Juniper Networks Inc (JNPR) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
JNPR does not have a complete income-statement cache yet.
ARWR currently screens at market cap $10.59B. JNPR currently screens at market cap $13.36B and trailing P/E 38.0.
Not investment advice. Open the ARWR and JNPR stock pages for the full models.
Not investment advice.